A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities.
about
Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment optionsTreating Negative Symptoms in Schizophrenia: an UpdatePsychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gapDopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and FutureNegative symptoms in schizophrenia.An Integrative Perspective on the Role of Dopamine in SchizophreniaStriatal dopamine receptor plasticity in neurotensin deficient mice.The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients.The hypocretin system and psychiatric disorders.Dopaminergic foundations of personality and individual differences.Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management.Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.Managing the comorbidity of schizophrenia and ADHD.The 10th Anniversary of the Eli Lilly Chair of Schizophrenia from the University of Montreal.The Black Book of Psychotropic Dosing and Monitoring.Effectiveness of Prescription-Based CNS Stimulants on Hospitalization in Patients With Schizophrenia: A Nation-Wide Register Study.Are negative symptoms in schizophrenia a distinct therapeutic target?Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis.Negative Symptoms and Cognitive Impairments in Schizophrenia: Two Key Symptoms Negatively Influencing Social Functioning.Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine
P2860
Q22241447-F7178DD6-8FF6-41BA-ADA0-0A48D81FB8BFQ26744805-F1B8E02F-19A8-405C-AFCB-2ECC0AD0CC61Q28081111-0A45D1CF-5641-4F96-91A0-DA75E33BA255Q28394341-D7948D9E-F125-4526-B038-8EF520C9102BQ33820512-E250E973-96A3-43C0-9ACC-F21342512B67Q33839379-F925E1B6-17DF-4A9F-86AE-ABCCA5493729Q35834247-BBFEC06B-7850-4526-959E-CEE790C07AE8Q37637480-F32D2458-E211-4B98-B9F3-1E9481FC10E6Q38173326-7D6C6F92-E4E8-4711-8FFA-A07B87E31F2AQ38268627-4117EC85-4837-4012-917B-706E3B8E539AQ38268878-821E0587-9A8E-4E69-907F-43AD63A39A33Q38647035-15AD0835-1BE5-4F09-A9A7-66596DB3E053Q38884279-CD5A73F3-BC8B-4F78-8C1C-00147DC9894FQ40320924-D19E0B13-2C68-48C3-82DA-AA41032D0A60Q41000600-04133B99-1589-4536-9548-F85CA3C0022AQ42575889-69B266C8-5463-408E-8946-F765158CBC75Q47642128-49CFFC97-77E6-43A4-969E-5D9AAD408C1EQ47756472-A0AAED86-B7FD-4233-A78D-80D8B5EF1721Q49381903-FB9AD3EE-B29E-4F7E-B740-FB64B8723BDEQ50192659-1C66A048-1688-4A63-A1DF-6ABFBF9F0F7DQ55383224-27F6656F-900A-4BF2-82DA-8462C26A3848Q59136721-A706C6C6-7E05-4B70-A59A-3A3E11B2925E
P2860
A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review of psychos ...... and therapeutic opportunities.
@en
type
label
A systematic review of psychos ...... and therapeutic opportunities.
@en
prefLabel
A systematic review of psychos ...... and therapeutic opportunities.
@en
P2093
P1476
A systematic review of psychos ...... and therapeutic opportunities.
@en
P2093
Henry Nasrallah
Jean-Pierre Lindenmayer
Michael Pucci
Steven James
P304
P356
10.1016/J.SCHRES.2013.03.019
P407
P577
2013-04-22T00:00:00Z